Clinical trials
Virus Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ModernaTX, Inc. | 9 |
| Imperial College London | 7 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| AstraZeneca | 2 |
| Gilead Sciences | 2 |
| PepTcell Limited | 2 |
| University of Edinburgh | 2 |
| Akhilesh Jha | 1 |
| Altesa Biosciences, Inc. | 1 |
| AusperBio Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Virus Diseases | 46 |
| COVID-19 | 14 |
| Influenza, Human | 12 |
| Coronavirus Infections | 10 |
| Infections | 9 |
| RNA Virus Infections | 9 |
| Respiratory Tract Infections | 9 |
| Severe Acute Respiratory Syndrome | 7 |
| Coronaviridae Infections | 5 |
| Nidovirales Infections | 5 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.